price jan usd
hold rate reect skeptic compani abl
attain sale growth margin target result sale growth
outpac estim margin came light mix implic
thing like
view organ sale growth guidanc achiev
contempl deceler across number custom end market
busi seem reectiv prudenc deterior
underli health adjust ep guidanc rang
straddl consensu estim
organ sale growth beat driven robust diagnost growth
report organ sale growth outpac
estim consensu organ sale growth
diagnost segment drove out-performance diagnost
segment reproduct health grew low-doubl digit
genom test busi grew prenat test grew high-
healthi china america growth china maintain double-
digit growth pace outlook contempl deceler
high-single-digit growth china sale growth america busi
acceler double-digit pace high-singl digit prior
quarter driven strength da busi particularli pharma/
biotech detect imag enterpris servic
thing cautiou
oper margin came light expect solid margin expans
adjust oper margin came well
forecast manag note sever factor weigh
margin includ divestitur multi-spectr imag busi
neg mix shift euroimmun busi advers impact
fx posit front outlook call basi
point bp oper margin expans omx omx acceler
reect downshift growth invest spend ramp
distribut gmt
deutsch bank seek busi compani cover research report thu investor
awar rm may conict interest could aect object report investor consid
report singl factor make invest decis disclosur analyst certif
across sever busi move past headwind relat
aforement busi divestitur revers fx headwind
experienc
apprehens quantifi vanadi sale outlook
manag reiter plan instrument vanadi
workow place year end shi away provid revenu
outlook manag expect key data public releas
mid-year continu remain cautiou vanadi opportun
see data
price target
rais price target reect higher peer
group multipl roll forward valuat framework price target
reect enterpris valu use project level debt cash
ebitda ex option estim end
multipl equival life scienc tool diagnost peer group median
forecast ratio
period end expens expens incom incom continu ep dilut con share share sale ex amort acquir cash flowoper cash cash revenu ep incl
period end asset equival st receiv current discontinu current equip secur asset asset asset discontinu liabil short-term liabil discontinu op current debt less current long-term liabil stockhold januari
price current end previou trade session unless otherwis indic sourc local exchang via reuter bloomberg vendor
inform sourc deutsch bank subject compani sourc disclosur pertain recommend estim made secur
primari subject research pleas see recent publish compani report visit global disclosur look-up page websit http //research db com/
research/disclosures/companysearch asid within report import risk conict disclosur also found http //research db com/research/topics/equ
investor strongli encourag review inform invest
import disclosur requir regul
disclosur mark asterisk may also requir least one jurisdict addit unit state see
import disclosur requir non-u regul explanatori note
deutsch bank and/or aliat receiv non-invest bank relat compens
compani within past year
compani client deutsch bank secur inc within past year time
import disclosur requir non-u regul
